Ginkgo Bioworks DNA Shares (Diluted)
Discontinued — last reported Q4 '25
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Ginkgo Bioworks’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's shares (diluted)?
- Ginkgo Bioworks (DNA) reported shares (diluted) of 55.5M in Q4 2025.
- How has Ginkgo Bioworks's shares (diluted) changed year-over-year?
- Ginkgo Bioworks's shares (diluted) increased by 6.9% year-over-year, from 51.9M to 55.5M.
- What is the long-term trend for Ginkgo Bioworks's shares (diluted)?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's shares (diluted) has grown at a -54.8% compound annual growth rate (CAGR), from 5.3B to 220.2M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.